BioWorld MedTech

March 2, 2012

Analysts see Staar on the verge of significant top line growth

Analysts at Canaccord Genuity are saying that Staar Surgical (Monrovia, California) could be poised for tremendous growth in the med-tech sector throughout the next few years. Read More

European Congress of Radiology: Abstracts push aside vendors as scientific program expands

Report from Europe: Trinity Biotech reports it will pay $13.1M for Fiomi Diagnostics

Washington roundup: FDA eyes doc label rule for devices; may expand liability

Financings report: Cardiff University spin-out secures 292,000 in funding

Med-Tech Notes: Berg Diagnostics gets CLIA certification

Deals roundup: Alere to acquire eScreen for about $270 million

Med-Tech Notes: Oxford Diagnostic opens Memphis lab

Restructuring roundup: Columbia Labs reports 42% workforce reduction

New ventures: EnTrust establishes a new healthcare properties division

Product Briefs

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

SERCA inhibitor from Sumitomo shows promise for MSA-C treatment

BioWorld Science

At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....